Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 14, 2011

Drug Name Review Type Class Manufacturer
Incivek New Drug Initial Review Hepatitis C Vertex
Victrelis New Drug Initial Review Hepatitis C Merck
Natroba New Drug Initial Review Pediculicide ParaPRO
Xarelto New Drug Initial Review Factor Xa Inhibitor Johnson & Johnson
Tradjenta New Drug Initial Review DPP-4 Inhibitor Boehringer-Ingelheim
Moxeza New Drug Initial Review Ophthalmic - Antibiotic Alcon